Medifast (MED) EBIAT (2016 - 2025)
Historic EBIAT for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.
- Medifast's EBIAT fell 236204.74% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 99254.3%. This contributed to the annual value of -$18.7 million for FY2025, which is 99296.99% down from last year.
- Latest data reveals that Medifast reported EBIAT of -$18.1 million as of Q4 2025, which was down 236204.74% from -$2.3 million recorded in Q3 2025.
- Medifast's 5-year EBIAT high stood at $47.0 million for Q2 2021, and its period low was -$18.1 million during Q4 2025.
- In the last 5 years, Medifast's EBIAT had a median value of $24.8 million in 2022 and averaged $19.5 million.
- Within the past 5 years, the most significant YoY rise in Medifast's EBIAT was 13041.45% (2025), while the steepest drop was 236204.74% (2025).
- Over the past 5 years, Medifast's EBIAT (Quarter) stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then plummeted by 86.73% to $801000.0 in 2024, then tumbled by 2362.05% to -$18.1 million in 2025.
- Its EBIAT was -$18.1 million in Q4 2025, compared to -$2.3 million in Q3 2025 and $2.5 million in Q2 2025.